• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
Technology

Thyme Care Raises Over $125 Million in Series E

Series E round led by Morgan Health addresses cancer care gaps.

TF
1 Source, 27d ago, first seen 27d ago

TLDR

Tech Funding News states that Thyme Care raised more than $125 million in a Series E round. The round was led by Morgan Health, the employer-healthcare investment arm of J.P. Morgan Chase. The company’s valuation doubled to over $2 billion in under a year. The funding targets gaps in cancer care. The details appear in the publication’s report and its associated post on X.

Combined views

72

1 Source, first seen 27d ago

Combined views

72

1 Source, first seen 27d ago

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

1 Source

@TFNBreakingNews🩺 @ThymeCares has raised more than $125 million in Series E funding, roughly doubling its valuation to over $2 billion in less than a year. https://techfundingnews.com/thyme-care-doubles-valuation-to-2b-with-125m-raise-to-tackle-gaps-in-cancer-care @MorganHealth, @JMorganchase’s employer-healthcare investment arm, led the round. @CVSHealth Ventures and @Humana returned as strategic backers, alongside @alley_corp, @HealthQuest_Cap, @ForesiteCapital, Concord Health Partners, Frist Cressey Ventures, @townhallvntrs, and @a16z Bio + Health. #ustech #healthtech #funding #investment #innovation #vcfunding #cancercare #valuation #technology #startups
    • HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI

    1 Source

    @TFNBreakingNews🩺 @ThymeCares has raised more than $125 million in Series E funding, roughly doubling its valuation to over $2 billion in less than a year. https://techfundingnews.com/thyme-care-doubles-valuation-to-2b-with-125m-raise-to-tackle-gaps-in-cancer-care @MorganHealth, @JMorganchase’s employer-healthcare investment arm, led the round. @CVSHealth Ventures and @Humana returned as strategic backers, alongside @alley_corp, @HealthQuest_Cap, @ForesiteCapital, Concord Health Partners, Frist Cressey Ventures, @townhallvntrs, and @a16z Bio + Health. #ustech #healthtech #funding #investment #innovation #vcfunding #cancercare #valuation #technology #startups
    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet